Encompass Health Co. (NYSE:EHC) Shares Bought by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC lifted its position in shares of Encompass Health Co. (NYSE:EHC) by 18.1% during the 4th quarter, HoldingsChannel reports. The fund owned 1,150,866 shares of the company’s stock after purchasing an additional 175,975 shares during the period. Encompass Health accounts for 1.1% of TimesSquare Capital Management LLC’s portfolio, making the stock its 26th biggest position. TimesSquare Capital Management LLC’s holdings in Encompass Health were worth $76,786,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of Encompass Health by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 9,546,953 shares of the company’s stock valued at $641,173,000 after buying an additional 31,380 shares in the last quarter. William Blair Investment Management LLC grew its holdings in shares of Encompass Health by 6.4% during the third quarter. William Blair Investment Management LLC now owns 5,676,379 shares of the company’s stock worth $381,226,000 after buying an additional 342,512 shares in the last quarter. Invesco Ltd. raised its position in shares of Encompass Health by 22.3% in the third quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock valued at $266,914,000 after buying an additional 724,544 shares during the last quarter. FMR LLC boosted its position in Encompass Health by 11.6% during the third quarter. FMR LLC now owns 1,374,755 shares of the company’s stock worth $92,329,000 after acquiring an additional 142,633 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its stake in Encompass Health by 2.3% during the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock valued at $87,989,000 after acquiring an additional 29,926 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In related news, EVP John Patrick Darby sold 14,543 shares of Encompass Health stock in a transaction on Monday, May 6th. The shares were sold at an average price of $83.94, for a total transaction of $1,220,739.42. Following the sale, the executive vice president now directly owns 84,773 shares in the company, valued at approximately $7,115,845.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP John Patrick Darby sold 14,543 shares of Encompass Health stock in a transaction on Monday, May 6th. The shares were sold at an average price of $83.94, for a total value of $1,220,739.42. Following the transaction, the executive vice president now directly owns 84,773 shares of the company’s stock, valued at approximately $7,115,845.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark J. Tarr sold 44,976 shares of the business’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total value of $3,745,151.52. Following the completion of the transaction, the chief executive officer now owns 554,098 shares in the company, valued at approximately $46,139,740.46. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Trading Up 1.3 %

Encompass Health stock traded up $1.08 during midday trading on Thursday, reaching $86.37. 503,823 shares of the stock traded hands, compared to its average volume of 665,236. The company has a 50-day simple moving average of $79.76 and a two-hundred day simple moving average of $72.05. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.14. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $86.60. The firm has a market cap of $8.70 billion, a PE ratio of 23.27, a price-to-earnings-growth ratio of 1.30 and a beta of 0.92.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.19. The business had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The company’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same period last year, the firm earned $0.88 earnings per share. Research analysts expect that Encompass Health Co. will post 4.1 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be paid a dividend of $0.15 per share. The ex-dividend date is Friday, June 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.69%. Encompass Health’s payout ratio is currently 16.22%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Truist Financial boosted their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. Stephens reissued an “overweight” rating and issued a $85.00 price objective on shares of Encompass Health in a report on Tuesday, January 16th. Mizuho increased their price target on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $90.29.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.